Analysis of riluzole’s profile of use in a Central Hospital in Lisbon

Figures & data

Figure 1 Adherence rate (AR) calculation.

Table 1 Patient comorbidities

Comorbidity	Number of patients (%)
Cancer	8 (10)
Endocrine disorder	20 (26)
Immune disorder	2 (3)
Blood disorder	7 (9)
Mental disorder	14 (18)
Nervous system disorder	17 (22)
Cardiovascular disease	50 (65)
Respiratory disorder	15 (19)
Digestive disorder	16 (21)
Skin disease	2 (3)
Muscular disorder	5 (6)

Figure 2 Patients requiring alternative routes of administration.

Abbreviation: PEG, percutaneous endoscopic gastrostomy.

Figure 3 Distribution of adherence rates.

Abbreviation: AR, adherence rate.

Figure 4 Suspected adverse drug reactions.